🇺🇸 FDA
Patent

US 12077605

Cysteine protease inhibitors and methods of use thereof

granted A61KA61K31/245A61K31/404

Quick answer

US patent 12077605 (Cysteine protease inhibitors and methods of use thereof) held by Anixa Biosciences, Inc. expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Anixa Biosciences, Inc.
Grant date
Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/245, A61K31/404, A61K31/427, A61K31/4418